2017 Funding Allocation Hero Background Image

The Research Battlefront

Together, we ride so rare cancer patients can live longer, better lives. 100% of every dollar raised has been invested in research led by Memorial Sloan Kettering—and together we are revolutionizing the way cancer is diagnosed and treated.

Together, we will beat rare cancers.

2018 Funding Allocation

2018 Funding Allocation

Every dollar of the $39 million raised in 2018 is funding innovative studies and clinical trials that are accelerating progress in the fight against rare cancers.

Discoveries

Discoveries

These research breakthroughs funded by Cycle for Survival highlight the pioneering research initiatives supported by this community that benefit rare cancer patients worldwide.

Discoveries

Research Updates

Research Updates

Research Updates

These trials, studies, and major research initiatives would not have been possible without Cycle for Survival support.

Equinox Innovation Initiative

Equinox Innovation Initiative

Cycle for Survival is proud to have Equinox as the founding partner, and the “Equinox Innovation Initiative” represents our shared commitment to pursuing bold ideas and innovative thinking.

Equinox Innovation Initiative

With every dollar, Cycle for Survival makes research possible.

Every single dollar raised through Cycle for Survival goes to rare cancer research, clinical trials, and leading-edge technologies at Memorial Sloan Kettering (MSK).

Support for research is all-encompassing and touches every stage of the scientific process. It drives everything from running and maintaining state-of-the-art labs, to sequencing tumors in search of cancer-causing genetic mutations, to creating laboratory models that scientists study to understand how cancer cells become resistant to treatment, bringing in and engaging the brightest, most talented teams, and so much more.

MSK runs more than 1,000 clinical trials—one of the largest clinical trial programs in the world. 120+ research laboratories are focused on better understanding every type of cancer. Cycle for Survival is essential to launching and sustaining these efforts. The funding empowers MSK doctors and scientists to pursue bold, new ideas that wouldn’t otherwise get off the ground. In many cases, this seed funding supports the critical first steps to establish the proof of concept needed to secure additional dollars from other sources.

The Cycle for Survival community is creating opportunities for discovery that are already changing the lives of everyone impacted by a rare cancer.